| Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults B Killingley, AJ Mann, M Kalinova, A Boyers, N Goonawardane, J Zhou, ... Nature Medicine 28 (5), 1031-1041, 2022 | 471 | 2022 |
| Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells GM Li, C Chiu, J Wrammert, M McCausland, SF Andrews, NY Zheng, ... Proceedings of the National Academy of Sciences 109 (23), 9047-9052, 2012 | 462 | 2012 |
| RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection A Jozwik, MS Habibi, A Paras, J Zhu, A Guvenel, J Dhariwal, M Almond, ... Nature communications 6 (1), 10224, 2015 | 313 | 2015 |
| Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus MS Habibi, A Jozwik, S Makris, J Dunning, A Paras, JP DeVincenzo, ... American journal of respiratory and critical care medicine 191 (9), 1040-1049, 2015 | 296 | 2015 |
| Metabolic phenotypes of response to vaccination in humans S Li, NL Sullivan, N Rouphael, T Yu, S Banton, MS Maddur, ... Cell 169 (5), 862-877. e17, 2017 | 274 | 2017 |
| Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans AH Ellebedy, F Krammer, GM Li, MS Miller, C Chiu, J Wrammert, ... Proceedings of the National Academy of Sciences 111 (36), 13133-13138, 2014 | 255 | 2014 |
| Protective and harmful immunity to RSV infection PJM Openshaw, C Chiu, FJ Culley, C Johansson Annual review of immunology 35 (1), 501-532, 2017 | 248 | 2017 |
| Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19 RS Thwaites, A Sanchez Sevilla Uruchurtu, MK Siggins, F Liew, ... Science immunology 6 (57), eabg9873, 2021 | 207 | 2021 |
| Antiviral B cell and T cell immunity in the lungs C Chiu, PJ Openshaw Nature immunology 16 (1), 18-26, 2015 | 202 | 2015 |
| Cathelicidins have direct antiviral activity against respiratory syncytial virus in vitro and protective function in vivo in mice and humans SM Currie, E Gwyer Findlay, AJ McFarlane, PM Fitch, B Böttcher, ... The Journal of Immunology 196 (6), 2699-2710, 2016 | 161 | 2016 |
| Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection MS Habibi, RS Thwaites, M Chang, A Jozwik, A Paras, F Kirsebom, ... Science 370 (6513), eaba9301, 2020 | 153 | 2020 |
| Tuberculosis infectiousness and host susceptibility RD Turner, C Chiu, GJ Churchyard, H Esmail, DM Lewinsohn, NR Gandhi, ... The Journal of infectious diseases 216 (suppl_6), S636-S643, 2017 | 142 | 2017 |
| Protective and dysregulated T cell immunity in RSV infection PJ Openshaw, C Chiu Current opinion in virology 3 (4), 468-474, 2013 | 125 | 2013 |
| Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study DL Fink, H Callaby, A Luintel, W Beynon, H Bond, EY Lim, ... The Lancet Infectious Diseases 23 (5), 589-597, 2023 | 85 | 2023 |
| Induction and subversion of human protective immunity: contrasting influenza and respiratory syncytial virus S Ascough, S Paterson, C Chiu Frontiers in Immunology 9, 323, 2018 | 75 | 2018 |
| B cell responses to influenza infection and vaccination C Chiu, AH Ellebedy, J Wrammert, R Ahmed Influenza Pathogenesis and Control-Volume II, 381-398, 2015 | 73 | 2015 |
| Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection A Guvenel, A Jozwik, S Ascough, SK Ung, S Paterson, M Kalyan, ... The Journal of clinical investigation 130 (1), 523-538, 2020 | 64 | 2020 |
| Current concepts and progress in RSV vaccine development AK Guvenel, C Chiu, PJM Openshaw Expert review of vaccines 13 (3), 333-344, 2014 | 62 | 2014 |
| Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells ND Verma, AD Lam, C Chiu, GT Tran, BM Hall, SJ Hodgkinson Scientific reports 11 (1), 10476, 2021 | 61 | 2021 |
| Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study J Zhou, A Singanayagam, N Goonawardane, M Moshe, FP Sweeney, ... The Lancet Microbe 4 (8), e579-e590, 2023 | 59 | 2023 |
Peter OpenshawProfessor of Experimental MedicineVerified email at imperial.ac.uk
